Ropivacaine and Midazolam by Intraarticular vs Epidural Administration in Arthroscopic ACL

NCT05078372 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2021-10-14

No results posted yet for this study

Summary

Compare of the effectiveness of the use of ropivacaine and midazolam by intraarticular vs epidural administration on post-operative analgesia after isolated arthroscopic anterior cruciate ligament (ACL) reconstruction with hamstring autograft.

Conditions

  • Anterior Cruciate Ligament Injuries
  • Anesthesia Injection Site
  • Knee Injuries

Interventions

DRUG

ropivacaine and midazolam intraarticular administration

Patients undergoing ACL reconstruction with hamstring autograft who will receive ropivacaine and midazolam epidural administration for anesthesic technique for the procedure, and intraarticular administration of those drugs.

DRUG

ropivacaine and midazolam epidural administration

Patients undergoing ACL reconstruction with hamstring autograft who will receive ropivacaine and midazolam epidural administration for anesthesic technique for the procedure

Sponsors & Collaborators

  • Universitat Autonoma de Barcelona

    collaborator OTHER
  • Universidad Autonoma de Nuevo Leon

    lead OTHER

Principal Investigators

  • Rodolfo Morales-Avalos, MSc, MD · University Hospital "Dr. José Eleuterio González", Universidad Autonoma de Nuevo León (U.A.N.L.)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-31
Primary Completion
2021-01-31
Completion
2021-02-05

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05078372 on ClinicalTrials.gov